-
One of the leading hospitals in the country has slashed infection rates with an approach called "positive deviance" (PD) that encourages frontline workers to share novel solutions to day-to-day problems.
-
How serious did Charlotte, NC-based Novant Health decide to take MRSA infections after an outbreak among premature infants left the hospital with two dead babies? Posters went up on the walls that featured a child in a hospital bed with the caption, "You could kill him with your bare hands."
-
As the Joint Commission makes preventing surgical-site infections (SSIs) a national patient safety goal next year some infection preventionists may be more ready than others to meet the full panoply of phased-in requirements.
-
The Minnesota Department of Health recommends the following for discontinuing contact isolation and "removing patient flags" for methicillin-resistant Staphylococcus aureus:
-
The Joint Commission new 2009 national patient safety goal to prevent central line-associated bloodstream infections (CA-BSIs; NPSG.07.04.01) calls for use of use of a common-sense but once controversial checklist to ensure a standardized protocol is followed for central venous catheter insertion.
-
The Joint Commission new national patient safety goal to prevent surgical-site infections (SSIs; NPSG.07.05.01) includes a requirement to look for SSIs out to 30 days after the procedure raising the difficult but critical issue of post- discharge surveillance.
-
Whereas its potential benefits remain uncertain, prostate-specific antigen (PSA) screening may be associated with psychological harms. There has been a recent update to the screening guidelines by the U.S. Preventive Services Task Force (USPSTF).
-
A very large prospective study found no evidence that nuts, corn, popcorn, or seeds increased diverticular disease or its complications.
-
A randomized controlled trial of newly diagnosed type 2 diabetic patients not on insulin showed an increased depression score in those performing home glucose monitoring and no improvement in glycemic control.
-
A short-acting dihydropyridine calcium channel blocker with a rapid onset of action has been approved for intravenous use to reduce blood pressure.
